Kenneth C Anderson Selected Research

Kenneth C Anderson Research Topics

Disease

535	Multiple Myeloma 05/2024 - 01/2002
264	Neoplasms (Cancer) 04/2024 - 01/2002
34	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 04/2003
32	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 04/2002
18	Disease Progression 01/2022 - 06/2005
17	Thrombocytopenia (Thrombopenia) 01/2024 - 05/2002
16	Lymphoma (Lymphomas) 01/2022 - 04/2003
11	Neutropenia 01/2022 - 12/2004
10	Anemia 01/2023 - 01/2009
10	Plasmacytoma 01/2017 - 09/2002
10	Peripheral Nervous System Diseases (PNS Diseases) 12/2015 - 07/2006
9	Residual Neoplasm 01/2024 - 11/2016
8	Fatigue 01/2022 - 07/2006
8	Leukemia 10/2019 - 04/2002
8	Bone Diseases (Bone Disease) 01/2019 - 01/2002
6	Carcinogenesis 01/2019 - 10/2007
6	Chromosomal Instability (Chromosome Stability) 09/2015 - 01/2002
5	Breast Neoplasms (Breast Cancer) 08/2021 - 02/2011
5	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2011 - 07/2005
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 09/2012
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 04/2002
4	Bites and Stings (Sting) 01/2022 - 06/2020
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 07/2006

Drug/Important Bio-Agent (IBA)

152	Bortezomib (Velcade)FDA Link 03/2024 - 05/2002
77	Proteasome InhibitorsIBA 03/2024 - 05/2002
71	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 02/2002
67	Lenalidomide (CC 5013)FDA Link 11/2023 - 11/2002
43	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2002
40	Thalidomide (Thalomid)FDA Link 01/2021 - 04/2002
37	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 10/2002
28	Monoclonal AntibodiesIBA 02/2024 - 04/2003
28	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2002
27	Immunomodulating AgentsIBA 11/2021 - 05/2002
26	CytokinesIBA 03/2024 - 01/2002
24	Melphalan (Alkeran)FDA LinkGeneric 05/2024 - 07/2002
24	AntigensIBA 04/2024 - 04/2003
23	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 02/2002
20	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2023 - 05/2005
18	NF-kappa B (NF-kB)IBA 07/2013 - 05/2002
16	pomalidomideIBA 02/2024 - 09/2006
14	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2003
13	Histone Deacetylase InhibitorsIBA 04/2024 - 04/2003
12	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2007
11	Peptides (Polypeptides)IBA 01/2021 - 06/2003
11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2002
10	Histone Deacetylases (Histone Deacetylase)IBA 04/2024 - 10/2003
10	B-Cell Maturation AntigenIBA 03/2024 - 07/2006
10	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 03/2002
10	UbiquitinIBA 01/2023 - 08/2006
10	Immunoconjugates (Immunoconjugate)IBA 12/2021 - 07/2004
10	perifosineIBA 07/2020 - 05/2006
10	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2009
10	EnzymesIBA 01/2018 - 10/2003
10	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2014 - 01/2003
9	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2024 - 01/2002
9	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2024 - 10/2002
9	Phosphotransferases (Kinase)IBA 12/2017 - 03/2004
8	daratumumabIBA 02/2024 - 02/2011
8	Alkylating AgentsIBA 01/2023 - 08/2006
8	Immunoglobulin M (IgM)IBA 01/2023 - 04/2003
8	elotuzumabIBA 12/2021 - 08/2008
8	LigandsIBA 10/2021 - 03/2002
8	Vorinostat FDA Link 01/2016 - 04/2003
8	tanespimycin (17AAG)IBA 12/2011 - 02/2006
8	Insulin-Like Growth Factor I (IGF-1)IBA 01/2009 - 08/2002
7	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2024 - 01/2003
7	Histones (Histone)IBA 01/2023 - 05/2009
7	carfilzomibIBA 10/2020 - 07/2013
7	Prednisone (Sone)FDA LinkGeneric 01/2018 - 08/2005
7	Immunoglobulin G (IgG)IBA 07/2014 - 07/2005
7	Rituximab (Mabthera)FDA Link 09/2010 - 01/2005
7	Antineoplastic Agents (Antineoplastics)IBA 05/2010 - 09/2002
6	isatuximabIBA 02/2024 - 08/2017
6	Messenger RNA (mRNA)IBA 01/2021 - 04/2002
6	AntibodiesIBA 11/2019 - 03/2002
6	marizomibIBA 09/2016 - 11/2005
6	PanobinostatIBA 10/2013 - 11/2011
6	CaspasesIBA 06/2013 - 11/2003
6	GlucocorticoidsIBA 07/2012 - 01/2005
6	Cytotoxins (Cytolysins)IBA 04/2009 - 07/2004
6	InterleukinsIBA 01/2009 - 05/2004
6	Insulin-Like PeptidesIBA 01/2009 - 01/2002
5	Insulin (Novolin)FDA Link 03/2024 - 08/2002
5	OligonucleotidesIBA 03/2024 - 02/2002
5	Complement System Proteins (Complement)IBA 01/2020 - 04/2003
5	ixazomibIBA 01/2018 - 08/2011
5	Zoledronic Acid (Zometa)FDA Link 03/2016 - 02/2009
5	Sirolimus (Rapamycin)FDA Link 11/2014 - 12/2004
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2012 - 06/2005
5	enzastaurinIBA 07/2011 - 02/2007
5	Protein Kinase CIBA 02/2009 - 05/2004
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 09/2012
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 06/2003
4	Chimeric Antigen ReceptorsIBA 12/2021 - 11/2019

Therapy/Procedure

207	Therapeutics 01/2024 - 01/2002
28	Drug Therapy (Chemotherapy) 03/2024 - 01/2002
22	Stem Cell Transplantation 01/2023 - 01/2002
22	Immunotherapy 01/2022 - 06/2003
11	Transplantation 01/2022 - 01/2002
4	Precision Medicine 12/2021 - 10/2015